Macrogenics (MGNX) Long-Term Deferred Tax (2014)

Macrogenics (MGNX) reported Long-Term Deferred Tax of $1.6 million for Q4 2014.

Macrogenics (MGNX) Long-Term Deferred Tax (2014) Analysis & Trends

Macrogenics (MGNX) has 1 years of Long-Term Deferred Tax data on file, last reported at $1.6 million in Q4 2014.

Long-Term Deferred Tax for Q4 2014 came in at $1.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2014 was $1.6 million (changed N/A YoY), and the FY2014 annual result was $1.6 million, changed N/A from the prior year.
Long-Term Deferred Tax steadied at $1.6 million in Q4 2014 per MGNX's latest filing.
Over five years, Long-Term Deferred Tax peaked at $1.6 million in Q4 2014 and troughed at $1.6 million in Q4 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Macrogenics	260.14 Mn	193.63 Mn	-

Download Data

Date	Value
Dec 31, 2014	1.60 Mn